Recent Updates
Recently added Catalysts

Natural Health Trends Corp.

NHTCFDA catalysts, PDUFA dates & pipeline intelligence
$0.75
▲ +0.01 · +1.98%

Financials

Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Quarterly Cash
Unlock full NHTC financials and dilution scoring
Quarter by quarter figures, cash trend and dilution risk.
Institutional-grade data · Cancel anytime
52W LOW $0.7052W HIGH $4.00
Volume
50.80 K
Value Traded
38.83 K
Short % Float
0.61%
Days to Cover
1.0
+0.72%Week
-21.98%1 Month
-56.66%3 Month
-72.99%6 Month

Cash Data

Unlock NHTC cash and runway
  • Monthly Burn
  • Burn Trend
  • Dilution Risk
  • SEC Filing

Key Stats

Market Cap
6.33 M
EPS (TTM)
-0.17
P/E Ratio
-
Ent. Value
-11.25 M
Total Shares
8.49 M
Float Shares
7.40 M
Insiders
12.89%
Institutions
12.50%

Upcoming Catalysts

FDA decisions, readouts and PDUFA dates · scored by probability of approval

Catalyst Drug / Treatment Stage Prob. of Approval Description Drug Type Therapeutic Area Source
Unlock every NHTC catalyst date and PoA score
Every FDA decision, readout and PDUFA date, with drug type, therapeutic area and a PoA score you can trade on.
Institutional-grade data · Cancel anytime
PoA blends historical approval base rates, trial design score and FDA review track record.

NHTC Catalyst Timeline

Dated clinical, regulatory and corporate events for Natural Health Trends Corp.

Unlock the full NHTC catalyst timeline
Every PDUFA date, readout, approval and corporate move, tiered by market impact and updated daily.
Institutional-grade data · Cancel anytime

Past FDA Catalysts and PDUFA Decisions

How NHTC actually traded into and out of each decision

Date Drug Catalyst Stage Reaction Event Move % Best Trade %
No matching catalysts
Unlock all NHTC historical catalysts
Institutional-grade data · Cancel anytime
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision

Drug Pipeline Intelligence

Unlock the NHTC pipeline intelligence model
Every scored asset with PTRS, rNPV, enrollment velocity and trial design quality.
Institutional-grade data · Cancel anytime

Clinical Trial Results

Readouts, endpoints and source filings for every NHTC program

Drug Name Indication Phase Date Trial Results SummaryTitleSource
Scroll for more · summaries link to the source press release
Unlock every NHTC trial readout
Institutional-grade data · Cancel anytime

Inside Trades

Unlock NHTC insider buying and selling
Monthly insider buys and sells against the stock price, with the insider sentiment reading.
Institutional-grade data · Cancel anytime
InsiderSideSharesPriceValueDate
MASON RANDALL ADirectorOption 1,664 230,498 held$0.00 12/15/2024
Unlock the full NHTC insider trade log
Institutional-grade data · Cancel anytime

Hedge Fund 13F Activity

Fund % of Portfolio Current MV Shares Owned Activity
No hedge fund reported a 13F position in NHTC for Q2 2026.
Unlock every fund holding NHTC
Every 13F position with quarter over quarter share flow and average entry price.
Institutional-grade data · Cancel anytime
Unlock hedge fund flows in NHTC
Shares held by hedge funds each quarter, and who bought or sold.

Ownership Trends

Sign in to see NHTC ownership
Insider and institutional ownership, quarter by quarter.

NHTC Short Interest

Shares sold short, counted twice a month.

0.61%
Short % of Float
of tradable shares sold short
44.8K
Shares Sold Short
+7.3% vs prior count
1.0 Low
Days to Cover
trading days of normal volume to buy every short share back
47.8K
Avg Daily Volume
the average used for days to cover
Unlock NHTC short interest history
Two years of days to cover and shares sold short, with every count and its change.
Institutional-grade data · Cancel anytime

Options Data

Option Volume

Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg

Option Chain Statistics

ExpiryCall VolPut VolVol P/CCall OIPut OIOI P/CIV CallIV Call OI-WtdIV Call Vol-WtdIV PutIV Put OI-WtdIV Put Vol-Wtd
2026-11-20
Unlock NHTC option chain statistics
Per-expiry call and put volume, open interest, put-call ratios and implied volatility.
Institutional-grade data · Cancel anytime

Real-Time Option Chain

CallsStrikePuts
LastVolOILastVolOI
No data available
Unlock the live NHTC option chain
Live calls and puts by strike: last price, volume and open interest for every expiry.
Institutional-grade data · Cancel anytime

Calls vs Puts by Expiry

CallsPutsLog scale
Unlock NHTC options analytics
Institutional-grade data · Cancel anytime

Competitive positioning

How NHTC ranks across every disease it competes in

Competitive Position is a premium feature
See how NHTC ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial

NHTC News

-NHTC
Oct 28, 2026
NHTCGeneral

Natural Health Trends Reports Third Quarter 2026 Financial Results

Natural Health Trends Corp. reported steady revenue of $7.6 million for Q3 2026, but a 20% decline from the previous year. The company narrowed its operating loss to $277,000, down from $643,000 in Q2 2026. Active Members increased to 27,040, reflecting efforts to improve member engagement despite ongoing challenges.

Read more →
-NHTC
Oct 21, 2026
NHTCConferences/Events
▼ -5.9%on this news

Natural Health Trends to Report Third Quarter 2026 Financial Results on October 28th

Natural Health Trends Corp. will announce its financial results for Q3 2026 on October 28, 2026, at 9:00 a.m. ET. A conference call will follow at 11:30 a.m. ET, hosted by President Chris Sharng and CFO Scott Davidson. The company markets premium personal care products under the NHT Global brand.

Read more →
-NHTC
Jul 29, 2026
NHTCGeneral
▼ -5.2%on this news

Natural Health Trends Reports Second Quarter 2026 Financial Results

Natural Health Trends Corp. reported a challenging second quarter in 2026, with revenue dropping 23% to $7.6 million and an operating loss of $643,000. The company is facing cautious consumer spending in China and regulatory uncertainties. However, it has implemented a restructuring program that has already generated significant cost savings.

Read more →
-NHTC
Jul 22, 2026
NHTCGeneral

Natural Health Trends to Report Second Quarter 2026 Financial Results on July 29th

Natural Health Trends Corp. will report its financial results for Q2 2026 on July 29. The results will be discussed in a conference call hosted by President Chris Sharng and CFO Scott Davidson. The call is scheduled for 11:30 a.m. Eastern Time on the same day.

Read more →
-NHTC
Apr 29, 2026
NHTCGeneral

Natural Health Trends Reports First Quarter 2026 Financial Results

Natural Health Trends Corp. reported a revenue of $9.2 million for Q1 2026, a 14% decline from the previous year. The company experienced an operating loss of $474,000 and a net loss of $154,000. Despite these challenges, management is optimistic about future growth opportunities and the upcoming 25th anniversary celebrations.

Read more →
-NHTC
Apr 22, 2026
NHTCConferences/Events

Natural Health Trends to Report First Quarter 2026 Financial Results on April 29th

Natural Health Trends Corp. will release its financial results for the first quarter of 2026 on April 29, 2026, at 9:00 a.m. Eastern Time. A conference call will follow at 11:30 a.m. Eastern Time, hosted by President Chris Sharng and CFO Scott Davidson. The company operates internationally, marketing wellness products under the NHT Global brand.

Read more →
-NHTC
Feb 17, 2026
NHTCGeneral

Natural Health Trends Announces Repurchase of All Outstanding Broady Shares

Natural Health Trends Corp. announced the repurchase of 2,935,227 shares from the Broady family for $5.9 million. This transaction, part of a $70 million repurchase program, reduces the total shares outstanding to 8,577,848. The company anticipates a decrease in annual dividend obligations by approximately $1.2 million.

Read more →
-NHTC
Feb 4, 2026
NHTCGeneral
▲ +6.7%on this news

Natural Health Trends Reports Fourth Quarter and Full Year 2025 Financial Results

Natural Health Trends Corp. reported a 10% decrease in net sales year over year but a 3% sequential increase for Q4 2025. The company has nearly completed its restructuring initiatives aimed at achieving $1.5 million in annual savings. Additionally, a quarterly cash dividend of $0.10 per share was declared.

Read more →
-NHTC
Jan 28, 2026
NHTCGeneral

Natural Health Trends to Report Fourth Quarter and Full Year 2025 Financial Results on February 4th

Natural Health Trends Corp. announced it will report its financial results for Q4 and the full year 2025 on February 4, 2026. The call will be hosted by President Chris Sharng and CFO Scott Davidson at 11:30 a.m. ET. The company operates internationally, marketing premium personal care products.

Read more →
-NHTC
Nov 5, 2025
NHTCGeneral
▼ -23.3%on this news· ran to -42% by day 1

Natural Health Trends Reports Third Quarter 2025 Financial Results

Natural Health Trends Corp. reported a third quarter 2025 revenue of $9.5 million, down 11% from the previous year. The company incurred an operating loss of $495,000 and a net loss of $431,000. To address financial challenges, management is implementing restructuring initiatives expected to yield $1.5 million in annual savings by mid-2026.

Read more →
-NHTC
Oct 29, 2025
NHTCGeneral

Natural Health Trends to Report Third Quarter 2025 Financial Results on November 5th

Natural Health Trends Corp. announced it will report its financial results for Q3 2025 on November 5, 2025. The report will be followed by a conference call at 11:30 a.m. Eastern Time, hosted by President Chris Sharng and CFO Scott Davidson. The company markets premium personal care products globally.

Read more →
-NHTC
Jul 30, 2025
NHTCGeneral

Natural Health Trends Reports Second Quarter 2025 Financial Results

Natural Health Trends Corp. reported a revenue decline of 6% to $9.8 million for Q2 2025. The company experienced an operating loss of $333,000, compared to a loss of $238,000 in the same quarter last year. Active Members also decreased to 29,260, reflecting ongoing economic challenges.

Read more →
-NHTC
Jul 23, 2025
NHTCConferences/Events

Natural Health Trends to Report Second Quarter 2025 Financial Results on July 30th

Natural Health Trends Corp. will announce its second quarter 2025 financial results on July 30, 2025. The report will cover the period ending June 30, 2025, and will be followed by a conference call hosted by President Chris Sharng and CFO Scott Davidson. This event will provide insights into the company's performance.

Read more →
-NHTC
Apr 30, 2025
NHTCGeneral

Natural Health Trends Reports First Quarter 2025 Financial Results

Natural Health Trends Corp. reported its Q1 2025 financial results, showing a revenue of $10.7 million, down 2% from the previous year. The company recorded a net income of $122,000 and a slight operating loss of $345,000. Despite challenges, management noted a 9% increase in orders from the previous quarter and declared a quarterly cash dividend.

Read more →
-NHTC
Apr 23, 2025
NHTCConferences/Events

Natural Health Trends to Report First Quarter 2025 Financial Results on April 30th

Natural Health Trends Corp. will announce its financial results for Q1 2025 on April 30, 2025, at 9:00 a.m. ET. The company's President, Chris Sharng, and CFO, Scott Davidson, will discuss the results during a conference call at 11:30 a.m. ET on the same day. This event highlights the company's ongoing operations in personal care and wellness products.

Read more →
-NHTC
Feb 5, 2025
NHTCGeneral

Natural Health Trends Reports Fourth Quarter and Full Year 2024 Financial Results

Natural Health Trends Corp. reported its fourth quarter and full year 2024 financial results, with revenue of $10.8 million, unchanged from Q4 2023. The company experienced a net income of $176,000, down from $358,000 year-over-year. Despite challenges in certain markets, the Hong Kong business saw a 9% revenue increase sequentially. A quarterly cash dividend of $0.20 was declared.

Read more →
-NHTC
Jan 29, 2025
NHTCConferences/Events

Natural Health Trends to Report Fourth Quarter 2024 Financial Results on February 5th

Natural Health Trends Corp. will announce its fourth quarter 2024 financial results on February 5, 2025. The results will be discussed in a conference call hosted by President Chris Sharng and CFO Scott Davidson at 11:30 a.m. Eastern Time. The company markets premium personal care products globally.

Read more →
-NHTC
Oct 30, 2024
NHTCGeneral

Natural Health Trends Reports Third Quarter 2024 Financial Results

Natural Health Trends Corp. reported a 1% increase in revenue to $10.7 million for Q3 2024. The operating loss improved to $275,000, while net income fell to $35,000. The company declared a quarterly cash dividend of $0.20 per share. Active Members decreased by 11% compared to the previous year.

Read more →
-NHTC
Oct 23, 2024
NHTCConferences/Events

Natural Health Trends to Report Third Quarter 2024 Financial Results on October 30th

Natural Health Trends Corp. will release its third quarter 2024 financial results on October 30, 2024. The report will be followed by a conference call hosted by President Chris Sharng and CFO Scott Davidson at 11:30 a.m. Eastern Time. The company markets personal care and wellness products under the NHT Global brand.

Read more →
-NHTC
Jul 31, 2024
NHTCGeneral

Natural Health Trends Reports Second Quarter 2024 Financial Results

Natural Health Trends Corp. reported its Q2 2024 financial results, showing a net income of $173,000, a significant improvement from a loss in Q2 2023. Revenue remained steady at $10.5 million, while operating loss improved to $238,000. The company also declared a quarterly cash dividend of $0.20 per share, payable on August 23, 2024.

Read more →

About Natural Health Trends Corp.

Rolling Hills Estates, CA 120 employees naturalhealthtrendscorp.com
Headquarters609 DEEP VALLEY DRIVE, SUITE 395, ROLLING HILLS ESTATES, CA, 90274
BIOPHARMAWATCH ELITE
Trade the next NHTC catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $24/mo billed annually.
Cancel anytime